How did The Cigna Group (NYSE:CI) perform in Q1 2026?

The Cigna Group reported Q1 2026 revenues of $68.5 billion, a 5% increase year-over-year. Shareholders' net income was $1.7 billion, or $6.26 per share. On an adjusted basis, income from operations was $2.1 billion, or $7.79 per share. The results were driven by strong performance in the Evernorth health services division and improved margins in the core insurance arm.

What drove The Cigna Group’s revenue growth in Q1 2026?

The 5% year-over-year revenue growth was driven by higher pharmacy volumes and disciplined medical cost management. Cigna also benefited from the strong performance of its Evernorth health services division, which saw growth due to expanded partnerships and the rising demand for specialty medications.

How did Cigna’s profitability perform in Q1 2026?

Cigna’s profitability showed strong results, with shareholders' net income reaching $1.7 billion, or $6.26 per share. Adjusted income from operations was $2.1 billion, or $7.79 per share, reflecting a resilient operating model despite broader healthcare sector shifts and macroeconomic challenges.

What role did the Evernorth health services division play in Q1 2026?

Evernorth was a key driver of Cigna's growth in Q1 2026, benefiting from expanded partnerships and the rising demand for specialty medications. The division’s strong performance helped offset challenges in other parts of the business, making it a central component of Cigna’s growth strategy.

How did Cigna Healthcare perform in Q1 2026?

Cigna Healthcare saw a notable improvement in its medical care ratio in Q1 2026. This improvement was supported by pricing discipline and a favorable evolution in legacy claims, which helped to boost profitability in the core insurance business.

Cigna hikes annual profit forecast as Evernorth and healthcare margins climb

Written by Jon CuthbertPublished Apr. 30 2026Last Updated Apr. 30 2026

The Cigna Group (NYSE:CI) reported first-quarter 2026 results that surpassed analyst expectations, driven by strong performance in its Evernorth health services division and improved margins within its core insurance arm.

Total revenues for the period reached $68.5 billion, a 5% increase year-over-year, as the company benefited from higher pharmacy volumes and disciplined medical cost management.

Shareholders' net income for the quarter was $1.7 billion, or $6.26 per share.

On an adjusted basis, income from operations stood at $2.1 billion, or $7.79 per share, reflecting a resilient operating model despite broader macroeconomic shifts in the healthcare sector.

The quarter was also marked by the financial effects of the HCSC transaction, part of Cigna's ongoing effort to sharpen its focus on high-growth areas like specialty pharmacy and Medicare Advantage.

Evernorth, the company’s health services brand, remained a primary engine of growth, benefiting from expanded partnerships and the rising demand for specialty medications.

Simultaneously, Cigna Healthcare saw a notable improvement in its medical care ratio, supported by pricing discipline and a favorable evolution in legacy claims.

Reflecting the momentum across its business units, Cigna raised its full-year 2026 adjusted income from operations outlook to at least $30.35 per share.